相关实验视频

Updated: Jul 15, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

与ER+/HER2-乳腺癌患者的瘤型DX风险组相关的临床病理因素

Ran Song¹, Dong-Eun Lee², Eun-Gyeong Lee¹

¹Department of Surgery, Center of Breast Cancer, National Cancer Center, Goyang 10408, Republic of Korea.

|September 28, 2023

概括

临床病理学因素可以预测早期乳腺癌的瘤型DX (ODX) 风险组,可能作为代价昂贵的基因分析的替代方案. 这些预测因素因患者年龄而异.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
临床病理学临床病理学

背景情况:

型DX (ODX) 试验预测早期乳腺癌的复发风险,但涉及高成本和漫长的测试.
识别替代预测因素对于有效的风险分层和治疗决策至关重要.

研究的目的:

确定能够预测早期乳腺癌ODX风险组的临床病理因素.
探索ODX风险分层的特定年龄预测因素.

主要方法:

对547名早期乳腺癌患者 (ER+,HER2-,节点阴性) 的回顾性分析,这些患者接受了ODX测试.
评估临床病理特征,包括BMI,更年期状态,手术类型和免疫组织化学标记 (Ki-67,p53,PR).
将患者分为不同的ODX风险类别的年龄组 (≤50和>50岁) 的分层.

主要成果:

在≤50岁的患者中,组织学级,孕激素受体 (PR) 表达,Ki-67和p53表达显著预测了ODX风险.
在50岁以上的患者中,瘤大小,Ki-67和p53表达与ODX风险显著相关.
这些发现突出了ODX风险组的年龄相关临床病理预测因素.

结论:

某些临床病理学因素可以有效地预测早期乳腺癌中的ODX风险类别.
特定于年龄的因素可以指导这些预测因素的选择,有助于对辅助化疗的决定.
这项研究为ODX测试提供了潜在的替代方案,提高了成本效益和周转时间.

关键词:

型DX是DX的型型.乳腺癌乳腺癌乳腺癌预测预测预测预测预后预后预后复发率得分复发率得分

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

相关概念视频

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...